China · Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 11.63 billion. The enterprise value is 10.05 billion.
| Market Cap | 11.63B |
| Enterprise Value | 10.05B |
Important Dates
The last earnings date was Tuesday, March 10, 2026.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:301087 has 203.20 million shares outstanding. The number of shares has decreased by -0.20% in one year.
| Current Share Class | 203.20M |
| Shares Outstanding | 203.20M |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | +1.65% |
| Owned by Insiders (%) | 11.25% |
| Owned by Institutions (%) | 14.83% |
| Float | 83.13M |
Valuation Ratios
The trailing PE ratio is 31.61 and the forward PE ratio is 25.89. SHE:301087's PEG ratio is 1.53.
| PE Ratio | 31.61 |
| Forward PE | 25.89 |
| PS Ratio | 3.43 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | 22.46 |
| P/OCF Ratio | 16.71 |
| PEG Ratio | 1.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.46, with an EV/FCF ratio of 19.42.
| EV / Earnings | 27.05 |
| EV / Sales | 2.97 |
| EV / EBITDA | 19.46 |
| EV / EBIT | 30.05 |
| EV / FCF | 19.42 |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.41 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 1.60 |
| Debt / FCF | 1.60 |
| Interest Coverage | 20.82 |
Financial Efficiency
Return on equity (ROE) is 7.63% and return on invested capital (ROIC) is 9.21%.
| Return on Equity (ROE) | 7.63% |
| Return on Assets (ROA) | 3.20% |
| Return on Invested Capital (ROIC) | 9.21% |
| Return on Capital Employed (ROCE) | 6.64% |
| Weighted Average Cost of Capital (WACC) | 9.45% |
| Revenue Per Employee | 666,699 |
| Profits Per Employee | 73,137 |
| Employee Count | 5,081 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, SHE:301087 has paid 55.53 million in taxes.
| Income Tax | 55.53M |
| Effective Tax Rate | 13.04% |
Stock Price Statistics
The stock price has increased by +60.47% in the last 52 weeks. The beta is 1.04, so SHE:301087's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +60.47% |
| 50-Day Moving Average | 56.48 |
| 200-Day Moving Average | 44.37 |
| Relative Strength Index (RSI) | 48.14 |
| Average Volume (20 Days) | 3,425,900 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 3.39 billion and earned 371.61 million in profits. Earnings per share was 1.81.
| Revenue | 3.39B |
| Gross Profit | 1.77B |
| Operating Income | 334.51M |
| Pretax Income | 425.84M |
| Net Income | 371.61M |
| EBITDA | 448.85M |
| EBIT | 334.51M |
| Earnings Per Share (EPS) | 1.81 |
Balance Sheet
The company has 2.44 billion in cash and 826.18 million in debt, with a net cash position of 1.61 billion or 7.93 per share.
| Cash & Cash Equivalents | 2.44B |
| Total Debt | 826.18M |
| Net Cash | 1.61B |
| Net Cash Per Share | 7.93 |
| Equity (Book Value) | 4.90B |
| Book Value Per Share | 23.95 |
| Working Capital | 2.25B |
Cash Flow
In the last 12 months, operating cash flow was 695.73 million and capital expenditures -178.10 million, giving a free cash flow of 517.63 million.
| Operating Cash Flow | 695.73M |
| Capital Expenditures | -178.10M |
| Depreciation & Amortization | 114.33M |
| Net Borrowing | -164.27M |
| Free Cash Flow | 517.63M |
| FCF Per Share | 2.55 |
Margins
Gross margin is 52.20%, with operating and profit margins of 9.87% and 10.97%.
| Gross Margin | 52.20% |
| Operating Margin | 9.87% |
| Pretax Margin | 12.57% |
| Profit Margin | 10.97% |
| EBITDA Margin | 13.25% |
| EBIT Margin | 9.87% |
| FCF Margin | 15.28% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.20%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 100.04% |
| Buyback Yield | 0.20% |
| Shareholder Yield | 3.40% |
| Earnings Yield | 3.20% |
| FCF Yield | 4.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
SHE:301087 has an Altman Z-Score of 3.93 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.93 |
| Piotroski F-Score | 6 |